WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 976

Summary of SB 976 (North Carolina, 2025 Session)

Title: Reduce Healthcare Costs and Protect Patients

Note: The following summary reflects the information provided in the bill entry and general legislative analysis conventions. If the bill text contains additional amendments or clarifications, those should be consulted for precise language.

1. Purpose and Intent

  • The bill is titled to “Reduce Healthcare Costs and Protect Patients,” indicating its overarching aim to lower costs within the healthcare system while strengthening protections for patients.
  • Primary goals typically include cost containment, transparency, and safeguards against practices that increase patient financial burden or compromise quality of care. (This summary reflects the stated title; the bill’s specific statutory language should be reviewed for exact aims and definitions.)

2. Key Provisions and Changes (High-Level)

  • Cost Reduction Measures: The bill is expected to introduce measures aimed at reducing out-of-pocket costs for patients and lowering overall healthcare expenditures. Potential areas often addressed in similar bills include price transparency, negotiated rates, and oversight of price increases.
  • Patient Protections: Provisions likely establish or strengthen patient protections, such as protections against surprise medical bills, improvements to notice and consent requirements, and protections related to access to essential services.
  • Price Transparency: The bill may require insurers, providers, or facilities to disclose pricing data (e.g., negotiated rates, charge descriptions, and cost estimates) to patients or regulators.
  • Regulation and Oversight: Potential creation or empowerment of a state health affordability or price transparency program, including reporting obligations, periodic reviews, and enforcement mechanisms.
  • Payment and Coverage Provisions: Possible reforms related to insurer practices, network adequacy, prior authorization processes, and coverage requirements that influence patient costs and access to care.
  • Consumer-directed Provisions: The bill might include consumer education components, cost-estimation tools, or assistance programs to help patients make informed healthcare choices.

Note: The exact statutory language will specify the precise mix of provisions, thresholds, timelines, and enforcement mechanisms.

3. Who or What Would Be Affected

  • Patients and Consumers: Direct impact through potential reductions in out-of-pocket costs and improved protections against balance billing or surprise charges.
  • Insurers and Employers: Indirectly affected via new transparency requirements, rate-reporting obligations, and potential constraints on pricing practices.
  • Healthcare Providers and Facilities: Subject to pricing disclosures, potential changes in reimbursement considerations, and administrative requirements.
  • State Agencies: Likely involvement from the Department of Insurance, Department of Health and Human Services, or a new or existing price transparency regulator to implement, monitor, and enforce provisions.

4. Procedural and Timeline Considerations

  • Status: Filed on 2026-04-30 (Co-sponsor: Lisa Grafstein).
  • Next Steps: As a filed bill, it would progress through committee hearings, potential amendments, and floor debate in both chambers. If enacted, anticipated effective dates would typically include:
    • Effective date for new requirements (e.g., 6–12 months after enactment or a specified date).
    • Compliance deadlines for insurers, providers, and state agencies.
  • Implementation: Depending on the bill’s complexity, phased implementation or separate rulemaking may accompany statute changes.

5. Additional Notes

  • Sponsor Information: Primary sponsor not listed in the summary, but co-sponsor is Lisa Grafstein.
  • To provide a precise, actionable summary, the final bill text should be reviewed for:
    • Definitions (e.g., “surprise billing,” “price transparency”).
    • Specific numeric thresholds, such as caps on cost-sharing or particular reporting metrics.
    • Enforcement mechanisms (fines, penalties, or corrective actions) and appeal processes.
    • Funding provisions for any new programs or agencies.

If you have access to the full text of SB 976, I can update this summary with exact sections, definitions, and statutory language.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.